EP0000784B1 - Dérivés de 4-hydroxy benzimidazolin-2-one, procédé de préparation et leurs compositions pharmaceutiques - Google Patents
Dérivés de 4-hydroxy benzimidazolin-2-one, procédé de préparation et leurs compositions pharmaceutiques Download PDFInfo
- Publication number
- EP0000784B1 EP0000784B1 EP78100633A EP78100633A EP0000784B1 EP 0000784 B1 EP0000784 B1 EP 0000784B1 EP 78100633 A EP78100633 A EP 78100633A EP 78100633 A EP78100633 A EP 78100633A EP 0000784 B1 EP0000784 B1 EP 0000784B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- general formula
- compound
- hydroxy
- tert
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 0 C*[C@]1(C/C(/*)=C(\*)/C(/O*N(**)ON)=C\C(C)(C)C1)N Chemical compound C*[C@]1(C/C(/*)=C(\*)/C(/O*N(**)ON)=C\C(C)(C)C1)N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Definitions
- DE-OS 2700193 describes 4-hydroxy-2-benzimidazolinone derivatives with a ⁇ -receptor blocking action, the fused benzene ring of which is unsubstituted.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (4)
et en ce qu'après ces réactions on transforme éventuellement les composés de formule générale l en sels pharmacologiquement tolérables, après avoir transformé éventuellement par acylation la fonction hydroxyle dans les composés de formule générale I dans lesquelles R3 est de l'hydrogène.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2736295 | 1977-08-12 | ||
DE2736295 | 1977-08-12 | ||
DE19782801953 DE2801953A1 (de) | 1978-01-18 | 1978-01-18 | 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
DE2801953 | 1978-01-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000784A1 EP0000784A1 (fr) | 1979-02-21 |
EP0000784B1 true EP0000784B1 (fr) | 1981-08-26 |
Family
ID=25772515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP78100633A Expired EP0000784B1 (fr) | 1977-08-12 | 1978-08-09 | Dérivés de 4-hydroxy benzimidazolin-2-one, procédé de préparation et leurs compositions pharmaceutiques |
Country Status (14)
Country | Link |
---|---|
US (1) | US4367235A (fr) |
EP (1) | EP0000784B1 (fr) |
JP (1) | JPS5432467A (fr) |
AT (1) | AT364831B (fr) |
AU (1) | AU3888578A (fr) |
CA (1) | CA1108619A (fr) |
DD (1) | DD137584A5 (fr) |
DE (1) | DE2860981D1 (fr) |
DK (1) | DK355378A (fr) |
ES (1) | ES472435A1 (fr) |
FI (1) | FI782452A (fr) |
IL (1) | IL55315A0 (fr) |
IT (1) | IT7826640A0 (fr) |
PT (1) | PT68404A (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0178413A1 (fr) * | 1984-08-17 | 1986-04-23 | Beecham Group Plc | Benzimidazoles |
US4554287A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones |
JPS63156809A (ja) * | 1986-12-19 | 1988-06-29 | Shin Etsu Chem Co Ltd | 塩化ビニル系重合体の製造方法 |
CA2085844A1 (fr) * | 1991-12-27 | 1993-06-28 | Nobuyuki Hamanaka | Derives fusionnes de l'acide benzeneoxyacetique |
WO1995004047A1 (fr) * | 1993-07-31 | 1995-02-09 | Smithkline Beecham Plc | Derives de 2-benzoheterocyclyloxy ou de thiopropanolamine a activite d'agoniste du recepteur adrenergique |
US6075040A (en) * | 1996-09-05 | 2000-06-13 | Eli Lilly And Company | Selective β3 adrenergic agonists |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
EP0827746B1 (fr) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Analogues de carbazole étant agonistes beta3-adrénergiques sélectifs |
CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
CN103445428A (zh) * | 2012-05-28 | 2013-12-18 | 苏州科羽电子技术服务有限公司 | 一种车座手提袋 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
CH624395A5 (fr) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag |
-
1978
- 1978-07-31 CA CA308,433A patent/CA1108619A/fr not_active Expired
- 1978-08-08 PT PT68404A patent/PT68404A/pt unknown
- 1978-08-08 IL IL7855315A patent/IL55315A0/xx unknown
- 1978-08-08 ES ES472435A patent/ES472435A1/es not_active Expired
- 1978-08-09 EP EP78100633A patent/EP0000784B1/fr not_active Expired
- 1978-08-09 IT IT7826640A patent/IT7826640A0/it unknown
- 1978-08-09 DD DD78207192A patent/DD137584A5/xx unknown
- 1978-08-09 DE DE7878100633T patent/DE2860981D1/de not_active Expired
- 1978-08-10 AT AT0582978A patent/AT364831B/de not_active IP Right Cessation
- 1978-08-10 FI FI782452A patent/FI782452A/fi not_active Application Discontinuation
- 1978-08-11 JP JP9811278A patent/JPS5432467A/ja active Pending
- 1978-08-11 DK DK355378A patent/DK355378A/da not_active Application Discontinuation
- 1978-08-14 AU AU38885/78A patent/AU3888578A/en active Pending
-
1980
- 1980-07-18 US US06/171,940 patent/US4367235A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1108619A (fr) | 1981-09-08 |
DD137584A5 (de) | 1979-09-12 |
DE2860981D1 (en) | 1981-11-19 |
FI782452A (fi) | 1979-02-13 |
AU3888578A (en) | 1980-02-21 |
ES472435A1 (es) | 1979-04-16 |
JPS5432467A (en) | 1979-03-09 |
US4367235A (en) | 1983-01-04 |
EP0000784A1 (fr) | 1979-02-21 |
PT68404A (de) | 1978-09-01 |
DK355378A (da) | 1979-02-13 |
IL55315A0 (en) | 1978-10-31 |
AT364831B (de) | 1981-11-25 |
IT7826640A0 (it) | 1978-08-09 |
ATA582978A (de) | 1981-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1695556C3 (de) | 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate | |
DE3119874A1 (de) | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" | |
EP0014951A2 (fr) | Dérivés hétérocycliques d'oxypropanolamine, procédé pour leur préparation et médicaments contenant ces composés | |
EP0000784B1 (fr) | Dérivés de 4-hydroxy benzimidazolin-2-one, procédé de préparation et leurs compositions pharmaceutiques | |
AT368130B (de) | Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen | |
EP0014928A1 (fr) | Dérivés de pipéridinopropyl, procédé pour leur préparation et médicaments contenant ces composés | |
DE2619164C2 (de) | Indazolyl-(4)-oxy-propanolamine, Verfahren zu ihrer Herstellung und deren Verwendung | |
EP0003298B1 (fr) | Dérivés de 4-hydroxy-2-benzimidazoline-thione, leur procédé de préparation et compositions pharmaceutiques les contenant | |
DE2535599C2 (de) | Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten | |
WO1979000426A1 (fr) | Diamine cyclique n, n'-disubstituee et procede pour sa preparation | |
AT344151B (de) | Verfahren zur herstellung von neuen naphthalinderivaten | |
EP0045911B1 (fr) | Dérivés de propanolamine, procédé pour leur préparation et médicaments contenant ces composés | |
DE2432269A1 (de) | Basisch substituierte derivate des 4-hydroxybenzimidazols und verfahren zu ihrer herstellung | |
DE2939914C2 (de) | N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoylbenzamid-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel | |
EP0029992B1 (fr) | Dérivés d'aminopropanol, procédé pour leur préparation et compositions pharmaceutiques contenant ces composés | |
AT375650B (de) | Verfahren zur herstellung von neuen 4-hydroxy-2 -benzimidazolinon-derivaten und von deren salzen, razematen und optisch aktiven formen | |
DE1906322A1 (de) | Neue alpha-Alkyl-5-hydroxytryptophanester | |
DE2923817B1 (de) | (3-Alkylamino-2-hydroxypropoxy)-furan-2-carbonsaeureanilide und deren physiologisch vertraegliche Saeureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen | |
EP0088986A2 (fr) | Ethers phénoliques bicycliques, procédé pour leur préparation ainsi que médicaments contenant ces composés | |
DE2801953A1 (de) | 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel | |
DE3886125T2 (de) | Harnstoff-Derivate. | |
DE2012667A1 (de) | Acyloxyalky!verbindungen, ihre Salze, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE3243820C2 (de) | N-Isopropylnoratropin-N-oxid, Verfahren für seine Herstellung und pharmazeutische Zubereitungen, die es enthalten | |
AT356101B (de) | Verfahren zur herstellung von neuen arylimino- imidazolidinderivaten und ihren salzen | |
DE3150055A1 (de) | Di-fanresyl-verbindungen und verfahren zu deren herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LU NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19810826 Ref country code: SE Effective date: 19810826 Ref country code: BE Effective date: 19810826 |
|
REF | Corresponds to: |
Ref document number: 2860981 Country of ref document: DE Date of ref document: 19811119 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19820831 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19831228 Year of fee payment: 5 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19840621 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19840820 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19840823 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19850831 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19860430 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19860501 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |